Skip to content
akaturk Academic measurement
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Farmakoloji
Academic summary YÖKSİS and OpenAlex counted separately.
Articles 119
YÖKSİS119 OpenAlex0
Projects 112
Books 9
Proceedings 62

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 65
h-index 19 Percentile in Türkiye: 97 #68 of 1,408 at their university by h-index
i10-index
33
Total citations
3,190
Top 0.7% in Türkiye
Per article
49.1
FWCI
3.01
1.00 = world average
World top 1%
4
World top 10%
16

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.

Field ranking

YÖKSİS ?

Index quartiles

?
Scopus (SJR) 72
  • Q1 23 %31.9
  • Q2 33 %45.8
  • Q3 11 %15.3
  • Q4 5 %6.9
WoS (JCR) 67
  • Q1 13 %19.4
  • Q2 20 %29.9
  • Q3 20 %29.9
  • Q4 14 %20.9
TR Index 8 articles
OpenAlex citation percentile
Top 1%5
Top 10%17
Avg · n 64 %70.2
Other counts

Scopus (SJR)

  • Excluding abstracts 64 Q1 22 Q2 29 Q3 11 Q4 2
  • YÖKSİS rows 74

WoS (JCR)

  • Excluding abstracts 62 Q1 13 Q2 17 Q3 18 Q4 14
  • YÖKSİS rows 69

TR Index

  • YÖKSİS rows 9 articles

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

119articles

Journals with publications

58 journals

Narrow down

Scopus (SJR)
WoS (JCR)
TR Index

Article list

  1. 2025 Chemical, antioxidant, anti-inflammatory, antibacterial, and cytotoxicity assessments of Apis mellifera intermissa venom collected in Northeast Algeria JOURNAL OF ASIA-PACIFIC ENTOMOLOGY DOI 10.1016/j.aspen.2025.102449 YÖKSİS SJR Q2 JCR Q2 OpenAlex 85.9%
  2. 2025 Effects of empagliflozin and its combination with docetaxel on LNCaP and DU-145 prostate cancer cell lines: cytotoxicity and molecular pathway analysis NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY DOI 10.1007/s00210-025-04132-9 YÖKSİS SJR Q2 JCR Q2 OpenAlex 4.4%
  3. 2025 Exploring the Antidiabetic Mechanisms of Taraxacum farinosum and Taraxacum mirabile Extracts: Enzyme Inhibition, Insulin Secretion, and LC-HRMS-Based Phytochemical Analysis CHEMISTRY & BIODIVERSITY DOI 10.1002/cbdv.202501160 YÖKSİS SJR Q2 JCR Q3 OpenAlex 68.4%
  4. 2025 Empagliflozin demonstrates cytotoxicity and synergy with tamoxifen in ER-positive breast cancer cells: anti-proliferative and anti-survival effects NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY DOI 10.1007/s00210-024-03316-z YÖKSİS SJR Q2 JCR Q2 OpenAlex 86.1%
  5. 2025 A Comprehensive Review Highlighting the Prospects of Phytonutrient Berberine as an Anticancer Agent JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY DOI 10.1002/jbt.70073 YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 94.7%
  6. 2024 Risk factors for early onset acute kidney injury after allogeneic haematopoietic stem cell transplantation and the role of drug–drug interactions European Journal of Hospital Pharmacy DOI 10.1136/ejhpharm-2023-003703 YÖKSİS SJR Q2 JCR Q4 OpenAlex 57.6%
  7. 2024 Development of Leech extract as a therapeutic agent: A chronological review Elsevier BV DOI 10.1016/j.prmcm.2023.100355 YÖKSİS SJR Q2 OpenAlex top 10% OpenAlex 95.3%
  8. 2024 Comparison of drug-drug interaction checking databases for interactions involving BCR-ABL tyrosine kinase inhibitors ISTANBUL JOURNAL OF PHARMACY DOI 10.26650/IstanbulJPharm.2024.1207607 YÖKSİS TR Index JCR Q4 OpenAlex 63.3%
  9. 2024 Comparison of Two Topical Pharmacological Agents in Alleviating Peripheral Intravenous Catheterization Induced Pain in Adults: A Randomized Controlled Study Journal of Clinical Practice and Research DOI 10.14744/cpr.2024.15497 YÖKSİS TR Index JCR Q4 OpenAlex 84.4%
  10. 2024 Xanthorrhizol: Its bioactivities and health benefits Journal of Applied Pharmaceutical Science DOI 10.7324/JAPS.2024.159484 YÖKSİS SJR Q2 OpenAlex 76.2%
  11. 2024 Detection of natural compounds by virtual screening, molecular docking and dynamics studies and evaluation of their effects on tau level in vitro Alzheimer’s model Journal of Biomolecular Structure and Dynamics DOI 10.1080/07391102.2023.2192806 YÖKSİS SJR Q2 JCR Q3 OpenAlex 50.6%
  12. 2024 WHICH TOOL IS THE BEST GUIDE OPTIMIZE THE VORICONAZOLE DOSAGE: THERAPEUTIC DRUG MONITORING OR CYTOCHROME P450 POLYMORPHISM? Sağlık Bilimleri Dergisi DOI 10.34108/eujhs.1337832 YÖKSİS OpenAlex 11.9%
  13. 2023 Investigation of Gold Nanoparticle Naproxen-Derived Conjugationsin Ovarian Cancer ACS Materials Au DOI 10.1021/acsmaterialsau.3c00033 YÖKSİS SJR Q1 JCR Q1 OpenAlex 86.7%
  14. 2023 Cancer and Nutrients CANCERS DOI 10.3390/cancers15164151 YÖKSİS SJR Q1 JCR Q1
  15. 2023 Editorial: Phytochemical-based nanoformulations to tackle drug resistance in cancer FRONTIERS IN PHARMACOLOGY DOI 10.3389/fphar.2023.1165596 YÖKSİS SJR Q1 JCR Q1
  16. 2023 Novel Strategies for the Bioavailability Augmentation and Efficacy Improvement of Natural Products in Oral Cancer CANCERS DOI 10.3390/cancers15010268 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 97.2%
  17. 2023 The Wound-Healing Potential of the Endemic Plant Helianthemum canum (L.) Baumg: Preclinical Studies Supported with Phytochemical Profiling. Chemistry & biodiversity DOI 10.1002/cbdv.202301529 YÖKSİS SJR Q2 JCR Q3 OpenAlex 66.6%
  18. 2023 Hematopoietik Kök Hücre Nakli Türüne ve Nakil Öncesi Mevcut Polifarmasiye Bağlı Olarak İlaç-İlaç Etkileşimi Farklılıkları Celal Bayar Universitesi Saglık Bilimleri Enstitusu Dergisi DOI 10.34087/cbusbed.1243203 YÖKSİS TR Index OpenAlex 21.8%
  19. 2022 The golden spice curcumin in cancer: A perspective on finalized clinical trials during the last 10 years Journal of Cancer Research and Therapeutics DOI 10.4103/jcrt.JCRT_1017_20 YÖKSİS SJR Q3 JCR Q4 OpenAlex top 10% OpenAlex 95.9%
  20. 2022 Neuroprotective Effects of Vapreotide on Tau Transfection-Induced Neurodegeneration NEUROTOXICITY RESEARCH DOI 10.1007/s12640-022-00588-2 YÖKSİS SJR Q2 JCR Q2 OpenAlex 44.7%

← Back to academicians